Molecular alterations identified in a phase 1 study of fostamatinib plus paclitaxel in platinum-resistant ovarian cancer.

Authors: Otavio de Carvalho Modaffar Al-Alam, Adam Luo, Tommy Wu, Tu-Yung Chang, Kelly Casella, Ellen Tully, Tian-Li Wang, Eugene Shenderov, Stephanie Gaillard

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17609

Source: Full article

---

Abstract

e17609